Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis.
Explore this paper's citation graph
Summary
Reperfusion and not thrombolytic agents per se appears to be the factor that induces platelet activation and consequently facilitates reocclusion.
- Type
- article
- Published
- 1992-03-01
- Cited by
- 15
- References
- 25
- OpenAlex
- https://openalex.org/W1970680342
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:24198242
Keywords
Medicine, Metabolite, Thromboxane A2, Excretion, Thrombolysis
References
- Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.
- Tissue-type plasminogen activator inhibits aggregation of platelets in vitro.
- Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
- Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker.
- Platelet Aggregation After Thrombolytic Therapy
- Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.
- Long-lived enzymatic metabolites of thromboxane B2 in the human circulation.
- Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis.
- Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man.
- Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation.
- ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early manag
- Tissue plasminogen activator promotes platelet disaggregation in plasma.
- Combined analysis of three noninvasive harkers for better prediction of reperfusion after thrombolytic therapy for acute myocardial infarction
- STREPTOKINASE-INDUCED, ANTIBODY-MEDIATED PLATELET AGGREGATION: A POTENTIAL CAUSE OF CLOT PROPAGATION IN VIVO
- Interactions between pharmacologic concentrations of plasminogen activators and platelets
- Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine.
- Thrombolysis: adjuvant therapy and the role of complement.
- Blood viscosity and platelet function in thrombolytic therapy of acute myocardial infarction.
- Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator.
- Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.
Cited by
- Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain
- Guidelines for the Management of Patients with Acute Myocardial Infarction
- High Plasma Concentrations of Cortisol and Thromboxane B2 in Patients With Depression
- Associated daily biosynthesis of cortisol and thromboxane A2: a preliminary report.
- Effect Of High Dose And Low Dose Aspirin On Survival Of Random Pattern Flaps In Rats
- Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage.
- Beta-thromboglobulin plasma levels in the first week after myocardial infarction: influence of thrombolytic therapy.
- Effect of aspirin on random pattern flap survival in rats
- Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man.
- Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial.
- Effect of Aspirin and Heparin on Random Skin Flap Survival in Rats
- Die experimentelle Untersuchung über die präventiven Wirkungen von API0134 gegen die Reokklusion nach der Thrombolyse der Koronararterien bei Hunden
- Comparison of Antithrombotic Effects of GPIIb-IIIa Receptor Antagonist and TXA2 Receptor Antagonist in the Guinea-pig Thrombosis Model: Possible Role of TXA2 in Reocclusion after Thrombolysis
- Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis.
- Effect of Aspirin and Heparin on Random Skin Flap Survival in Rats
- Early Spontaneous Intermittent Myocardial Reperfusion During Acute Myocardial Infarction Is Associated With Augmented Thrombogenic Activity and Less Myocardial Damage
- Platelet Activity in the Early Stage of Acute Myocardial Infarction: Relation to Time of Presentation, Treatment with Either Tissue Plasminogen Activator or Streptokinase and Cyclooxygenase Inhibition
Related papers
- The role of thrombolysis in the management of thromboembolic disorders: a four-year review.
- Effect of intravenous thrombolysis of Alteplase in treatment of acute ischemic stroke
- Metabolism of the neuroleptic agent zetidoline in the rat and the dog.
- [Therapeutic assessment between the thrombolysis in 6 hours and delayed thrombolysis after onset of acute myocardial infarction].
- The Preliminary Study of Thrombolysis on Acute Ischemic Stroke with Mid minidose Urokinase
- Dynamic Change of Serum Matrix Metalloproteinase-12 after Thrombolysis in Acute Myocardial Infarction and Its Clinical Significance
- Thromboxane Responsiveness of Dog Platelets Is Inherited as an Autosomal Recessive Trait
- Influence on thromboxane and malondialdehyde synthesis in human thrombocytes by various inhibitors of platelet function.
- Influence of co-incubation and cell number of platelets and polymorphonuclear leukocytes in cellular inhibition and activation phenomena.